Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial
Resource Type
Article
Authors
Marks, David I ; Kirkwood, Amy A ; Rowntree, Clare J ; Aguiar, Melanie ; Bailey, Katharine E ; Beaton, Brendan ; Cahalin, Paul ; Castleton, Anna Z ; Clifton-Hadley, Laura ; Copland, Mhairi ; Goldstone, Anthony H ; Kelly, Richard ; Lawrie, Emma ; Lee, SooWah ; McMillan, Andrew K ; McMullin, Mary Frances ; Menne, Tobias F ; Mitchell, Rachel J ; Moorman, Anthony V ; Patel, Bela ; Patrick, Pip ; Smith, Paul ; Taussig, David ; Yallop, Deborah ; Alapi, Krisztina Zuborne ; Fielding, Adele K
Source
In The Lancet Haematology April 2022 9(4):e262-e275
Subject
Primary Research Articles
Language
ISSN
2352-3026